Volume dodolan mangsa ngarep perusahaan: NeuroBo Pharmaceuticals Inc (NRBO)

Simbol resmi perusahaan NeuroBo Pharmaceuticals, Inc. (NRBO)

NeuroBo Pharmaceuticals (NRBO) is strengthening its position in the fight against diabetic neuropathy through Korean partners and patents. The company's future sales figures demonstrate this growth, where 0.00 serves as the base parameter value. Successes in obesity therapy in the US provide stability, while operating profitability is supported by the diversification of international supply chains for biochemical components.

Pendapatan sing dikarepake perusahaan: NeuroBo Pharma (NRBO) kanggo 04.07.2022 - 07.12.2024

Rincian analitis perusahaan NeuroBo Pharmaceuticals

- nilai saham lan prakiraan konsensus rega:
Produk merek NeuroBo

Investors are evaluating the potential of NeuroBo Pharmaceuticals (NRBO) through the lens of future cash flows. The metric calculates expected revenue as a derivative of market capitalization and asset growth rates. The trend in the company's projected revenue reflects the market consensus regarding the success of clinical trials and FDA approval. For the biotech sector, this indicator serves as a measure of confidence in the R&D strategy. The growth of this metric confirms the investment attractiveness of the issuer's therapeutic formulas.

Pesaing NeuroBo Pharmaceuticals

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|Neurogene Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan AC Immune S.A. ACIU|Dodolan mangsa ngarep perusahaan Voyager Therapeutics (VYGR)|Neumora - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SCLX|Tevogen Bio Inc. (TVGN) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan ACOG|CGTX (cogrx.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan inhibikase.com (IKT)|Prakiraan pendapatan perusahaan Cassava Sciences Inc (SAVA)|Dodolan mangsa ngarep perusahaan Assertio|Prakiraan volume dodolan COYA (Coya Therapeutics, Inc.)|Prakiraan volume pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|OVID: Volume dodolan mangsa ngarep perusahaan|ABOS: Prakiraan pendapatan perusahaan|CervoMed (CRVO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PEPG (PepGen)|Volume dodolan mangsa ngarep perusahaan JUNS (Jupiter Neurosciences, Inc.)|Prakiraan volume dodolan relmada.com (RLMD)|Prakiraan pendapatan perusahaan Annovis Bio Corp ANVS|GRCE: Prakiraan pendapatan perusahaan|AIFF - Prakiraan pendapatan perusahaan|KLTO (anewmeds.com) - Prakiraan pendapatan perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Volume dodolan mangsa ngarep perusahaan|revivapharma.com - Pendapatan mangsa ngarep perusahaan|MTVA (metaviatx.com) - Prakiraan volume dodolan|NRXS: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan HSDT|PASG - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan NEUP (Neuphoria Therapeutics)|NERV: Prakiraan pendapatan perusahaan|ATHA: Volume dodolan mangsa ngarep perusahaan|Addex Therapeutics Ltd - Prakiraan volume pendapatan perusahaan|Alzamend Neuro, Inc. (ALZN) - Prakiraan pendapatan perusahaan|CYCN (Cyclerion Therapeutics Inc.) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan PTIX|KTTA: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Brainstorm Cell Therapeutics, Inc. BCLI|Pendapatan mangsa ngarep perusahaan CARA|chromocell.com - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan ELYM|ITCI: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Longboard Pharmaceuticals, Inc. (LBPH)|Prakiraan pendapatan perusahaan Marinus Pharmaceuticals, Inc.|NKGN: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics